Researchers from the University of Waterloo have developed a new technology that can hold an entire course of antibiotics in ...

On Monday, Oct. 14, the Buena Vista Board of Education heard another parent comment regarding bullying and harassment in BV ...

Researchers from the University of Waterloo have developed a new technology that can hold an entire course of antibiotics in ...

Award from Highly Competitive Initiative Will Enable Ancilia to Advance Its Lead Program through IND Filing for Its First Clinical ...

DARE-HPV is a potential first-in-category treatment for human papillomavirus (HPV)-related cervical disease which could ...

"My son is homeschooled now because he’s not safe in your school." After sitting through board reports, policy reviews, and ...

Just as Smita Gopinath, Ph.D., was setting up her microbiology and immunology lab at Harvard T.H. Chan School of Public ...

However, in mid-2023, early results from a trial comparing BV-AVD with the newer N-AVD regimen found outcomes in people ...

For patients with stage III or IV Hodgkin lymphoma, nivolumab with doxorubicin, vinblastine, and dacarbazine (N+AVD ...

In mid-2023, the SWOG S1826 phase 3 trial in advanced Hodgkin lymphoma reported highly positive primary results earlier than expected, after the trial’s second planned interim analysis found the ...

The app is a critical tool for rural health care, providing timely insights that ensure patients don’t slip through the ...

It may be due to any number of factors that include certain sexually transmitted infections and similar genital tract conditions such as bacterial vaginosis/vaginitis and candidiasis. The new offering ...